Ticker | Value | Shares | Price | Security | Type | Insider | Title | Return | Flags | Date |
|---|---|---|---|---|---|---|---|---|---|---|
| No transactions found | ||||||||||
Frank Atlee V III currently holds 76,914 shares of ANTIGENICS INC /DE/ (AGEN), valued at approximately $0. This represents their equity stake as Executive.
Based on SEC Form 4 filings, Frank Atlee V III has been a net seller of AGEN stock. They have purchased $0 and sold $1.7M worth of shares.
Frank Atlee V III's most recent insider trade was on Dec 20, 2010, when they sold 1,422 shares at $0.00 per share.
Frank Atlee V III serves as Executive at ANTIGENICS INC /DE/ (AGEN). They have executed 29 insider transactions totaling $1.7M over their tenure at the company.
Frank Atlee V III holds the position of Executive at ANTIGENICS INC /DE/, where they are responsible for executive-level decision-making and strategic oversight. They have been associated with the company for 20 years and currently hold a stake valued at $0.
Frank Atlee V III has shown a selling trading pattern, with $0 in total purchases and $1.7M in total sales across all transactions. Their most recent activity indicates a tendency to reduce their position.
The largest transaction by Frank Atlee V III was on Apr 18, 2006, when they sold $1.7M worth of MON shares. This transaction involved 20,000 shares at $86.00 per share.
Frank Atlee V III currently owns 76,914 shares of ANTIGENICS INC /DE/ (AGEN), with an estimated value of $0. This stake represents their equity holdings accumulated through purchases, awards, and option exercises.
All of Frank Atlee V III's SEC Form 4 insider trading filings are tracked on this page. Each transaction links directly to the official SEC EDGAR filing. Frank Atlee V III has 29 Form 4 filings on record as an insider at ANTIGENICS INC /DE/.
Set alerts for Frank Atlee V III and 40,000+ other insiders.